Kascaid develops a biosensor platform that measures immune biomarkers on demand by sampling interstitial fluid. This technology provides precise, low-burden immune monitoring outside of traditional lab settings. The platform delivers dense, real-time immune activity data for use in clinical trials, research, and patient care.
Funding
Funding not disclosed
Founders
Product
Problem
Current immune monitoring depends on intermittent venipuncture blood draws, which introduce sample degradation and provide only snapshot data that can miss rapid changes in immune activity.
Solution
Kascaid offers a biosensor platform that extracts immune biomarkers directly from dermal interstitial fluid, delivering laboratory‑grade molecular measurements at the point of skin. The system enables on‑demand sampling, eliminating the need for scheduled blood draws and reducing patient burden. By accessing a stable, cell‑free matrix, the platform captures cleaner and denser data that reflect true physiological states. Real‑time results are streamed to a secure cloud analytics layer, where they can be integrated into clinical trial dashboards, research pipelines, or patient‑care workflows. This approach supports more frequent, precise immune profiling across drug development, translational research, and clinical management.
Target Audience
Primary customers are pharmaceutical and biotechnology companies conducting immune‑focused clinical trials, academic and contract research organizations studying immunology, and healthcare providers managing patients with chronic inflammatory or autoimmune conditions.
Features
- Wearable microfluidic sensor that non‑invasively samples dermal interstitial fluid (dISF) for immune biomarkers
- On‑demand assay activation with automated reagent delivery and micro‑scale proteomic detection
- Integrated electronics for real‑time signal acquisition and secure wireless transmission to cloud services
- Cloud‑based analytics pipeline that normalizes, stores, and visualizes biomarker trajectories for longitudinal studies
- Compatibility with standard clinical trial data management systems via API and FHIR‑aligned endpoints
- Supports a panel of cytokines, chemokines, and acute‑phase proteins with sub‑picogram sensitivity
- HIPAA‑compliant data handling, end‑to‑end encryption, and role‑based access controls
- Low‑burden user experience requiring minimal training, suitable for both clinical and home settings